406 related articles for article (PubMed ID: 18607173)
41. Plasminogen activator and plasminogen activator inhibitor gene expression in human saphenous vein organ culture.
Javed Q; Swanson N; Warner EL; Gershlick AH; de Bono DP
Exp Mol Pathol; 2001 Apr; 70(2):146-53. PubMed ID: 11263957
[TBL] [Abstract][Full Text] [Related]
42. Augmentation of arterial endothelial cell expression of the plasminogen activator inhibitor type-1 (PAI-1) gene by proinsulin and insulin in vivo.
Nordt TK; Sawa H; Fujii S; Bode C; Sobel BE
J Mol Cell Cardiol; 1998 Aug; 30(8):1535-43. PubMed ID: 9737940
[TBL] [Abstract][Full Text] [Related]
43. Pro- and antifibrinolytic properties of human pulmonary microvascular versus artery endothelial cells: impact of endotoxin and tumor necrosis factor-alpha.
Muth H; Maus U; Wygrecka M; Lohmeyer J; Grimminger F; Seeger W; Günther A
Crit Care Med; 2004 Jan; 32(1):217-26. PubMed ID: 14707582
[TBL] [Abstract][Full Text] [Related]
44. PERIOD2 is a circadian negative regulator of PAI-1 gene expression in mice.
Oishi K; Miyazaki K; Uchida D; Ohkura N; Wakabayashi M; Doi R; Matsuda J; Ishida N
J Mol Cell Cardiol; 2009 Apr; 46(4):545-52. PubMed ID: 19168071
[TBL] [Abstract][Full Text] [Related]
45. Cholesterol diet enhances daily rhythm of Pai-1 mRNA in the mouse liver.
Kudo T; Nakayama E; Suzuki S; Akiyama M; Shibata S
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E644-51. PubMed ID: 15361354
[TBL] [Abstract][Full Text] [Related]
46. [Effects of TNF-alpha or mmLDL on PAI-1 expression in human umbilical vein endothelial cells].
Li XD; Zu SY; Zhu GJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):156-9. PubMed ID: 12905793
[TBL] [Abstract][Full Text] [Related]
47. Attenuation by fibrates of plasminogen activator inhibitor type-1 expression in human arterial smooth muscle cells.
Nordt TK; Lutzi S; Ruef J; Peter K; Klar E; Kübler W; Sobel BE; Bode C
Thromb Haemost; 2001 Nov; 86(5):1305-13. PubMed ID: 11816722
[TBL] [Abstract][Full Text] [Related]
48. Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus.
Ludwig S; Dharmalingam S; Erickson-Nesmith S; Ren S; Zhu F; Ma GM; Zhao R; Fenton JW; Ofosu FA; Velthuis HT; van Mierlo G; Shen GX
Diabetes Res Clin Pract; 2005 Nov; 70(2):110-8. PubMed ID: 16188573
[TBL] [Abstract][Full Text] [Related]
49. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
[TBL] [Abstract][Full Text] [Related]
50. Proxisome proliferator-activated receptor-α mediates high-fat, diet-enhanced daily oscillation of plasminogen activator inhibitor-1 activity in mice.
Hayashida S; Kuramoto Y; Koyanagi S; Oishi K; Fujiki J; Matsunaga N; Ikeda E; Ohdo S; Shimeno H; Soeda S
Chronobiol Int; 2010 Oct; 27(9-10):1735-53. PubMed ID: 20969520
[TBL] [Abstract][Full Text] [Related]
51. Fenofibrate inhibits thrombogenic and fibrinolytic factors expression in adipose tissue of atherosclerotic rabbits.
Zhao SP; Li J; Xu Z; Wu J; Li Q; Ye H
Clin Chim Acta; 2004 Nov; 349(1-2):81-6. PubMed ID: 15469859
[TBL] [Abstract][Full Text] [Related]
52. Ghrelin attenuates plasminogen activator inhibitor-1 production induced by tumor necrosis factor-alpha in HepG2 cells via NF-kappaB pathway.
Ding L; Liu G; Guo W; Zhao H; Zong Z
Cell Biol Int; 2008 Oct; 32(10):1310-7. PubMed ID: 18700166
[TBL] [Abstract][Full Text] [Related]
53. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation.
Alessi MC; Bastelica D; Mavri A; Morange P; Berthet B; Grino M; Juhan-Vague I
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1262-8. PubMed ID: 12750120
[TBL] [Abstract][Full Text] [Related]
54. Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease.
Seth D; Hogg PJ; Gorrell MD; McCaughan GW; Haber PS
J Hepatol; 2008 Apr; 48(4):614-27. PubMed ID: 18289715
[TBL] [Abstract][Full Text] [Related]
55. Tissue-type plasminogen activator and plasminogen activator inhibitor type-1 mRNA and their protein expression levels in human decidua after early pregnancy termination by mifepristone plus misoprostol.
Huang L; Shi Y
Chin Med J (Engl); 2001 Jun; 114(6):628-31. PubMed ID: 11780441
[TBL] [Abstract][Full Text] [Related]
56. Plasminogen activator inhibitor-1 expression and secretion are stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes.
Kralisch S; Klein J; Lossner U; Blüher M; Paschke R; Stumvoll M; Fasshauer M
Mol Cell Endocrinol; 2006 Jul; 253(1-2):56-62. PubMed ID: 16713670
[TBL] [Abstract][Full Text] [Related]
57. Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering.
Haslinger B; Goedde MF; Toet KH; Kooistra T
Kidney Int; 2002 Nov; 62(5):1611-9. PubMed ID: 12371961
[TBL] [Abstract][Full Text] [Related]
58. HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins.
Wiesbauer F; Kaun C; Zorn G; Maurer G; Huber K; Wojta J
Br J Pharmacol; 2002 Jan; 135(1):284-92. PubMed ID: 11786505
[TBL] [Abstract][Full Text] [Related]
59. Homocysteine modulates the effect of simvastatin on expression of ApoA-I and NF-kappaB/iNOS.
Mikael LG; Rozen R
Cardiovasc Res; 2008 Oct; 80(1):151-8. PubMed ID: 18540024
[TBL] [Abstract][Full Text] [Related]
60. Simvastatin suppresses dexamethasone-induced secretion of plasminogen activator inhibitor-1 in human bone marrow adipocytes.
Sakamoto K; Osaki M; Hozumi A; Goto H; Fukushima T; Baba H; Shindo H
BMC Musculoskelet Disord; 2011 Apr; 12(1):82. PubMed ID: 21524281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
